Role of endoscopic retrograde pancreatography for early detection of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 20, Issue 3, 2013, Pages 356-361

  Ohtsuka, Takao ^a   Ideno, Noboru ^a   Aso, Teppei ^a   Nagayoshi, Yosuke ^a   Kono, Hiroshi ^a   Mori, Yasuhisa ^a   Takahata, Shunichi ^a   Oda, Yasunori ^a   Aishima, Shinichi ^a   Igarashi, Hisato ^a   Ito, Tetsuhide ^a   Ishigami, Kousei ^a   Nakamura, Masafumi ^a   Mizumoto, Kazuhiro ^a   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

ERCP; ERP; IPMN; Pancreatic ductal adenocarcinoma

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE PANCREATOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PANCREATOGRAPHY; PATIENT SELECTION; PREVALENCE; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; ENDOSONOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PANCREATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84879692963     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-012-0541-7     Document Type: Article

References (28)

1. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32.
2. Tanaka M, Fernandez-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183-97.
3. Yamaguchi K, Ohuchida J, Ohtsuka T, Nakano K, Tanaka M. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology. 2002;2:484-90.
4. Tanno S, Nakano Y, Koizumi K, Sugiyama Y, Nakamura K, Sasajima J, et al. Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms. Pancreas. 2010;39:36-40.
5. Tanno S, Nakano Y, Sugiyama Y, Nakamura K, Sasajima J, Koizumi K, et al. Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasms. Pancreatology. 2010;10:173-8.
6. Sawai Y, Yamao K, Bhatia V, Chiba T, Mizuno N, Sawaki A, et al. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. Endoscopy. 2010;42:1077-84.
7. Ingkakul T, Sadakari Y, Ienaga J, Satoh N, Takahata S, Tanaka M. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg. 2010;251:70-5.
8. Yamaguchi K, Kanemitsu S, Hatori T, Maguchi H, Shimizu Y, Tada M, et al. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas. 2011;40:571-80.
9. Maguchi H, Tanno S, Mizuno N, Hanada K, Kobayashi G, Hatori T, et al. Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan. Pancreas. 2011;40:364-70.
10. Ohtsuka T, Kono H, Tanabe R, Nagayoshi Y, Mori Y, et al. Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Am J Surg 2012;204:44-48.
11. Tanaka M. Controversies in the management of pancreatic IPMN. Nat Rev Gastroenterol Hepatol. 2011;8:56-60.
12. Fujita N, Noda Y, Kobayashi G, Kimura K, Ito K. Endoscopic approach to early diagnosis of pancreatic cancer. Pancreas. 2004;28:279-81.
13. Ross WA, Wasan SM, Evans DB, Wolff RA, Trapani LV, Staerkel GA, et al. Combined EUS with FNA and ERCP for evaluation of patients with obstructive jaundice from presumed pancreatic malignancy. Gastrointest Endosc. 2008;68:461-6.
14. Ogawa Y, Tanaka M, Inoue K, Yamaguchi K, Chijiiwa K, Mizumoto K, et al. A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus. Cancer. 2002;94:2344-9.
15. Inoue K, Ohuchida J, Ohtsuka T, Nabae T, Yokohata K, Ogawa Y, et al. Severe localized stenosis and marked dilation of the main pancreatic duct are indicators of pancreatic cancer instead of chronic pancreatitis on endoscopic retrograde balloon pancreatography. Gastrointest Endosc. 2003;58:510-5.
16. McGuire DE, Venu RP, Brown RD, Etzkorn KP, Glaws WR, Abu-Hammour A. Brushing cytology for pancreatic carcinoma: an analysis of factors influencing results. Gastrointest Endosc. 1996;44:300-4.
17. Yokohata K, Shirahane K, Yonemasu H, Nabae T, Inoue K, Ohtsuka T, et al. Focal ductal branch dilation on magnetic resonance cholangiopancreatography: a hint for early diagnosis of pancreatic carcinoma. Scand J Gastroenterol. 2000;35:1229-32.
18. Mori Y, Ohtsuka T, Tsutsumi K, Yasui T, Sadakari Y, Ueda J, et al. Multifocal pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasms of the pancreas, detected by intraoperative pancreatic juice cytology: report of a case. JOP. 2010;11:389-92.
19. Sadakari Y, Ienaga J, Kobayashi K, Miyasaka Y, Takahata S, Nakamura M, et al. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodule. Pancreas. 2010;39:232-6.
20. Adsay NV, Kloppel G, Fukushima N, Offerhaus GJA, Furukawa T, Pitman MB, et al. Intraductal papillary-mucinous neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. World Health Organization classification of tumors, pathology and genetics of tumors of the digestive system. Lyon: IARC Press; 2010. p. 304-13.
21. Japan Pancreas Society. Classification of pancreatic carcinoma. 2nd ed revised in English. Tokyo: Kanehara; 2002.
22. Tanaka M, Yokohata K, Konomi H, Yamaguchi K, Chijiiwa K, Ohta M. Segmental balloon cytology for preoperative localization of in situ pancreatic cancer. Gastrointest Endosc. 1997;46:447-9.
23. Poon RT, Yeung C, Lo CM, Yuen WK, Liu CL, Fan ST. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc. 1999;49:593-8.
24. Yamaguchi K, Nakamura M, Shirahane K, Kawamoto M, Konomi H, Ohta M, et al. Pancreatic juice cytology in IPMN of the pancreas. Pancreatology. 2005;5:416-21.
25. Inagaki M, Maguchi M, Kino S, Obara M, Ishizaki A, Onodera K, et al. Mucin-producing tumors of the pancreas: clinicopathological features, surgical treatment, and outcome. J Hepatobiliary Pancreat Surg. 1999;6:281-5.
26. Ishikawa O, Imaoka S, Ohigashi H, Nakaizumi A, Uehara H, Wada A, et al. A new method of intraoperative cytodiagnosis for more precisely locating the occult neoplasms of the pancreas. Surgery. 1992;111:294-300.
27. Iiboshi T, Hanada K, Fukuda T, Yonehara S, Sasaki T, Chayama K. Value of cytodiagnosis using endoscopic nasopancreatic drainage for early diagnosis of pancreatic cancer: establishing a new method for the early detection of pancreatic carcinoma in situ. Pancreas. 2012;41:523-9.
28. Kikuyama M, Itoi T, Ota Y, Matsuyama K, Tsuchiya T, Itokawa F, et al. Therapeutic endoscopy for stenotic pancreatodigestive tract anastomosis after pancreatoduodenectomy. Gastrointest Endosc. 2012;73:376-82.